SARS-CoV-2: from herd immunity to hybrid immunity

Herd immunity, where a pathogen can no longer efficiently spread in a population, is achieved when a large proportion of the population becomes immune, making the spread of infection from person to person unlikely and protecting those without immunity. Despite the global spread of SARS-CoV-2, the fa...

Descripción completa

Detalles Bibliográficos
Autor principal: Goldblatt, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016684/
https://www.ncbi.nlm.nih.gov/pubmed/35440758
http://dx.doi.org/10.1038/s41577-022-00725-0
_version_ 1784688579406987264
author Goldblatt, David
author_facet Goldblatt, David
author_sort Goldblatt, David
collection PubMed
description Herd immunity, where a pathogen can no longer efficiently spread in a population, is achieved when a large proportion of the population becomes immune, making the spread of infection from person to person unlikely and protecting those without immunity. Despite the global spread of SARS-CoV-2, the failure of virus- and vaccine-induced immunity to prevent transmission, combined with the emergence of antigenically distinct variants, has made herd immunity to SARS-CoV-2 unachievable thus far. Where does this leave us?
format Online
Article
Text
id pubmed-9016684
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90166842022-04-19 SARS-CoV-2: from herd immunity to hybrid immunity Goldblatt, David Nat Rev Immunol Comment Herd immunity, where a pathogen can no longer efficiently spread in a population, is achieved when a large proportion of the population becomes immune, making the spread of infection from person to person unlikely and protecting those without immunity. Despite the global spread of SARS-CoV-2, the failure of virus- and vaccine-induced immunity to prevent transmission, combined with the emergence of antigenically distinct variants, has made herd immunity to SARS-CoV-2 unachievable thus far. Where does this leave us? Nature Publishing Group UK 2022-04-19 2022 /pmc/articles/PMC9016684/ /pubmed/35440758 http://dx.doi.org/10.1038/s41577-022-00725-0 Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Goldblatt, David
SARS-CoV-2: from herd immunity to hybrid immunity
title SARS-CoV-2: from herd immunity to hybrid immunity
title_full SARS-CoV-2: from herd immunity to hybrid immunity
title_fullStr SARS-CoV-2: from herd immunity to hybrid immunity
title_full_unstemmed SARS-CoV-2: from herd immunity to hybrid immunity
title_short SARS-CoV-2: from herd immunity to hybrid immunity
title_sort sars-cov-2: from herd immunity to hybrid immunity
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016684/
https://www.ncbi.nlm.nih.gov/pubmed/35440758
http://dx.doi.org/10.1038/s41577-022-00725-0
work_keys_str_mv AT goldblattdavid sarscov2fromherdimmunitytohybridimmunity

Ejemplares similares